Science News
from research organizations

Type 2 diabetes patients 'let down' over delayed treatment

Date:
April 26, 2016
Source:
University of Leicester
Summary:
'Clinical inertia' is preventing tight control of blood sugar levels, a new report suggests. Research has shown the average waiting time for increased treatment for Type 2 diabetes from the start of insulin is 3.7 years.
Share:
FULL STORY

People with Type 2 diabetes are being 'let down' because they are being forced to wait for further treatment when needed.

Research has shown the average waiting time for increased treatment from the start of insulin is 3.7 years.

Maintaining tight control of blood sugars in people with Type 2 diabetes can lead to significant reductions in related complications, previous evidence has shown.

However 'clinical inertia', which is the term given for the delay of increasing medication needed for patients, is preventing this from happening, according to a study published in the Diabetes, Obesity and Metabolism journal.

The research was carried out by NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, an organisation which turns research into cost-saving and high-quality care through cutting-edge innovation.

Professor Kamlesh Khunti, Director of CLAHRC East Midlands and Professor of Primary Care Diabetes & Vascular Medicine at the University of Leicester based at the Leicester Diabetes Centre, said: "Of the 11,000 patients we studied, only a third of those needing further medication were actually given it.

"Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.

"Failure by healthcare professionals to intensify medication in the pursuit of tighter glycaemic control is due to a number of complex reasons related to patient and health care professional factors. However, we need to make great efforts to reverse these trends and improve patients reaching tight glucose targets from diagnosis of diabetes"

The study concluded that more should be done to avoid clinical inertia and patients should have their treatment intensified where appropriate.

Long-term complications and mortality associated with Type 2 diabetes can be significantly reduced if therapies are initiated earlier.


Story Source:

Materials provided by University of Leicester. Note: Content may be edited for style and length.


Journal Reference:

  1. K. Khunti, A. Nikolajsen, B. L. Thorsted, M. Andersen, M. J. Davies, S. K. Paul. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes, Obesity and Metabolism, 2016; 18 (4): 401 DOI: 10.1111/dom.12626

Cite This Page:

University of Leicester. "Type 2 diabetes patients 'let down' over delayed treatment." ScienceDaily. ScienceDaily, 26 April 2016. <www.sciencedaily.com/releases/2016/04/160426092128.htm>.
University of Leicester. (2016, April 26). Type 2 diabetes patients 'let down' over delayed treatment. ScienceDaily. Retrieved May 27, 2017 from www.sciencedaily.com/releases/2016/04/160426092128.htm
University of Leicester. "Type 2 diabetes patients 'let down' over delayed treatment." ScienceDaily. www.sciencedaily.com/releases/2016/04/160426092128.htm (accessed May 27, 2017).

RELATED STORIES